Sort
82,697 grants matching “vaccine development”
CIVIC SARS-CoV-2 Research Activities
$688,075Tony Moody · Duke University · N01 · FY2022 · AI
Modulation of Human Cells by Virulent Francisella tularensis
$688,064Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
A Systems Biology Approach to Malaria Immunity
$687,931Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2019 · AI
Estimating Cholera Burden with Cross-sectional Immunologic Data
$687,902Daniel Ted Leung · University Of Utah · R01 · FY2019 · AI
MHC-bound, SIV-derived, CTL & HTL Epitopes
$687,869David I Watkins · University Of Wisconsin-Madison · R24 · FY2008 · RR
Developing capsid-importin alpha inhibitors for the treatment of VEEV infection
$687,849Mikell Paige · George Mason University · R01 · FY2022 · AI
A Novel Oral Combination Pediatric HIV and TB Vaccine
$687,840Kristina Abel · University Of California At Davis · R01 · FY2008 · DE
Regulation of CD8+ T cell immunity to tuberculosis
$687,808Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$687,634Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2020 · AI
An HB Vaccine Model For HIV Vaccine Trials in Drug Users
$687,629University Of Texas Hlth Sci Ctr Houston · R01 · FY2005 · DA
GLYCOSYLATION MUTANTS OF LEISHMANIA
$687,571Stephen M Beverley · Washington University · R01 · FY2006 · AI
Preclinical Development of SB 44 as an Orally Bioavailable Anti-HBV Agent
$687,555Radhakrishnan P Iyer · Spring Bank Technologies, Inc. · R01 · FY2013 · AI
Microneedle-based immunization against pandemic influenza
$687,516Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2010 · EB
Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity
$687,506Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2021 · AI
Neisserial porins and antigen presenting cells
$687,504Lee Mark Wetzler · Boston Medical Center · R01 · FY2018 · AI
Neisserial porins and antigen presenting cells
$687,504Lee Mark Wetzler · Boston Medical Center · R01 · FY2019 · AI
Glanders Vaccine Developement
$687,491Donald E. Woods · University Of Calgary · U01 · FY2010 · AI
Vaccines Against Botulism
$687,469Joseph T. Barbieri · Medical College Of Wisconsin · R01 · FY2021 · AI
Negative regulation of innate immunity in influenza virus infection
$687,400Jian-Dong Li · Georgia State University · R01 · FY2025 · AI
Project 1: Human and Non-human Primate Influenza B-cell Repertoires
$687,400Michael Anthony Moody · Boston Children'S Hospital · P01 · FY2023 · AI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$687,398Harvinder Singh Gill · Texas Tech University · R01 · FY2022 · AI
Role of Teleost Fish B Cell Subsets in Innate and Adaptive Immunity Against Pathogens
$687,396Oriol Sunyer · University Of Pennsylvania · · FY2010 · BIO
Project 2
$687,394Maria Virginia Pascual · St. Jude Children'S Research Hospital · U19 · FY2024 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$687,393Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2020 · AI
Genetics of Coxiella burnetii
$687,387Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI